Stereotactic Body Radiotherapy (SBRT/SABR)

Acute Toxicity Following PSMA-Directed Focal Salvage Robotic SBRT for Local Recurrences Following Prior Robotic Prostate SBRT

Acute Toxicity, Patient-Reported Outcomes, and Radiological Evaluation Following MR-Guided Dose-Escalated Short Course Radiotherapy (SCRT) to the Pelvis

Adequate Reporting Standards Are Required to Study the Reirradiation Treatment Effects in the Clinic (ReTEC)

Advancing Treatment Planning for Ultra-High Dose Stereotactic Ablative Radiosurgery (SABR)

Bridging the Gap: A Model for Safe Adoption of Lung SBRT in Routine Practice

Early Impact of Pretreatment Colonoscopies and Colonic Findings on Post Prostate Stereotactic Body Radiation Therapy (SBRT) Gastrointestinal (GI) Patient-Reported EPIC Quality of Life

Health-Related Quality of Life Following Robotic Stereotactic Body Radiation Therapy for High-Risk Prostate Cancer

Integration of Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) in Management of Inoperable Pancreatic Cancer

Outcome Analysis of Lung SBRT Administered by a Single Radiation Oncologist at an Institution

Overall Survival and Local Control of Hepatic Metastatic Lesions Treated with Stereotactic Body Radiotherapy

Patient Age and Decision in Proceeding with Stereotactic Body Radiation Therapy for Men with Newly Diagnosed Prostate Cancer

Preliminary Results of the Comparison of the Efficacy of Conventional and Unconventional Radiotherapy in Paragangliomas of Head and Neck Treatment

Prognostic Evaluation of NLR and ALBI with Local Control in Hepatocellular Carcinoma Treated with SBRT and Hypofractionated RT

Region and Language Centric Virtual Education and Training in Latin America: Stereotactic Body Radiotherapy and Radiosurgery Curriculum in Spanish for Medical Physicists and Radiation Oncologists

Single-Fraction Stereotactic Body Radiotherapy (SBRT) Treatment to Early-Stage Primary Lung Tumors or Oligometastatic Lesions Confers Effective Local Control with Minimal Toxicity

ZZZAn International Patterns of Practice Survey of SABR Utilization in Primary Renal Cell Carcinoma